Its curated data source includes quality-managed entries of over 3 properly,700 strains from about 2,000 well-characterized microbial species. Beginning with a cultured colony, identification is conducted by matching the measured proteins fingerprint against the proprietary MALDI Biotyper data source. Like the database search, automatic identification can be carried out in mins. Multiple colonies can be spotted about the same target, and about 30-60 identifications can be carried out every hour. The MALDI Biotyper gives rapid time-to-result, high specificity, suprisingly low false positive rates, low operational costs, and low technical barriers for new operators. Related StoriesResearchers use genomic techniques to show why different strains of Salmonella infect particular pet speciesPatients with Down syndrome encounter additional challenge of early-onset dementiaAnalyzing potential TB vaccineBruker offers installed over 150 MALDI Biotyper systems world-wide in routine laboratories for microbiology, and the MALDI Biotyper is rapidly learning to be a new regular for robust, rapid microbial identification.Thanks for keeping us educated of your progress by using the hashtag #14Days to talk about your stories.
Accelitech embarks on a proton cancer therapy project Accelitech LLC, the first choice in the advancement and full-cycle administration of technology-driven cancers treatment programs, is very happy to announce its inaugural proton therapy task. The treatment center project, under development now, is the latest in Accelitech’s ongoing work to provide leading treatment systems to more individuals through joint-venture partnerships with doctors and hospitals.